Phil Brooks, a Black American, patented a disposable syringe design on April 9, 1974, contributing to safer healthcare. While ...

BANGOR -- At the corner of I-395 and Odlin Road is the Bangor Park & Ride. According to Brewer resident Danny McDougal, on ...

Seattle’s Material Recovery Facility (MRF) is a cacophonic, colorful symphony of industry, and it almost never stops—because ...

The "Hypodermic Syringes and Needles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Hypodermic ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

Authors Key Points Media Contact For general and media inquiries and to book our experts, please contact: [email protected] ...

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

The organization has also created a category of foundational initiatives called “Big Rocks”—critical investments required to operate effectively, regardless of short-term financial return.

The U.S. Food and Drug Administration (FDA) has approved Dutch biotech argenx’s (NASDAQ:ARGX) (OTCPK:ARGNF) autoimmune disease drug Vyvgart Hytrulo, developed with Halozyme Therapeutics (NASDAQ:HALO), ...